Literature DB >> 30324743

Circulating microRNA signatures serve as potential diagnostic biomarkers for Helicobacter pylori infection.

Jie Yu1, Qiaoxia Xu2, Xiaoyu Zhang3, Miao Zhu4.   

Abstract

Helicobacter pylor (H pylori), a Gram-negative, microaerobic human pathogen, has been found to be involved in many gastroduodenal diseases. Accurate diagnosis of H pylori infection is a vital part of the effective management of gastroduodenal diseases. Circulating microRNAs (miRNAs) have shown the potential to be used as noninvasive biomarkers for the diagnosis of infectious diseases. The aim of this study was to explore plasma miRNAs as noninvasive biomarkers for H pylori infection. We performed a plasma miRNA expression profile using Illumina high-throughput sequencing and validated the levels of differentially expressed miRNAs in the plasma of 63 H pylori-infected patients and 41 healthy volunteers by quantitative real-time polymerase chain reaction (qRT-PCR). The sequencing results showed that 37 miRNAs were upregulated in the H pylori-infected patients compared with that in the healthy volunteers, while six miRNAs were downregulated. qRT-PCR and receiver operator characteristic analysis suggested that the expression of miR-28-3p, miR-143-3p, miR-151a-3p, and miR-148a-3p were closely associated with H pylori infection. Therefore, the four plasma miRNA panels mentioned above could serve as promising noninvasive biomarkers of H pylori infection.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Helicobacter pylori (zzm321990H pylori); biomarker; miR-143-3p; miR-148a-3p; miR-151a-3p; miR-28-3p

Year:  2018        PMID: 30324743     DOI: 10.1002/jcb.27462

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  6 in total

1.  Monocyte subpopulation profiling indicates CDK6-derived cell differentiation and identifies subpopulation-specific miRNA expression sets in acute and stable coronary artery disease.

Authors:  Anika Witten; Leonie Martens; Monika Stoll; Birgit Markus; Ann-Christin Schäfer; Christian Troidl; Sabine Pankuweit; Ann-Kathrin Vlacil; Raghav Oberoi; Bernhard Schieffer; Karsten Grote
Journal:  Sci Rep       Date:  2022-04-04       Impact factor: 4.379

2.  Effects of hsa-miR-28-5p on Adriamycin Sensitivity in Diffuse Large B-Cell Lymphoma.

Authors:  Shufang Yan; Qinyu Shang; Haipeng Zhu; Ken Chen; Xinxia Li; Hongliang Gao; Bo Liu; Mei Feng; Lixia Gao
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-13       Impact factor: 2.650

Review 3.  Genomic Analyses of Non-Coding RNAs Overlapping Transposable Elements and Its Implication to Human Diseases.

Authors:  Eun Gyung Park; Hongseok Ha; Du Hyeong Lee; Woo Ryung Kim; Yun Ju Lee; Woo Hyeon Bae; Heui-Soo Kim
Journal:  Int J Mol Sci       Date:  2022-08-11       Impact factor: 6.208

4.  miRNAs from Plasma Extracellular Vesicles Are Signatory Noninvasive Prognostic Biomarkers against Atherosclerosis in LDLr-/-Mice.

Authors:  Ke-Feng Zhai; Hong Duan; Yan Shi; Ya-Ru Zhou; Yuan Chen; Yao-Shuai Zhang; Zi-Peng Gong; Wen-Gen Cao; Jia Wu; Jun-Jun Wang
Journal:  Oxid Med Cell Longev       Date:  2022-08-17       Impact factor: 7.310

Review 5.  What Is New in Helicobacter pylori Diagnosis. An Overview.

Authors:  Maria Pina Dore; Giovanni Mario Pes
Journal:  J Clin Med       Date:  2021-05-13       Impact factor: 4.241

6.  High-Throughput RNA Sequencing Analysis of Plasma Samples Reveals Circulating microRNA Signatures with Biomarker Potential in Dengue Disease Progression.

Authors:  Jaya Saini; Abhay Deep Pandey; Bhaswati Bandyopadhyay; V G Ramachandran; Shukla Das; Vikas Sood; Arup Banerjee; Sudhanshu Vrati
Journal:  mSystems       Date:  2020-09-15       Impact factor: 6.496

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.